INFANRIX POLIO

INJ SUS ISP 20X0,5ML+40J

SÚKL code 0208138
Name of the product INFANRIX POLIO
_MA_MEDICATION_DETAIL_INFO_MED_NAME i INFANRIX POLIO
Supplement INJ SUS ISP 20X0,5ML+40J
Strenght
Pharmaceutical form Suspension for injection in pre-filled syringe
Package 20X0,5ML+40J
Route Intramuscular use
Language of the pack Czech
Wrap type Pre-filled syringe
Legal status na lékařský předpis
Active substance DIPHTHERIA TOXOID (DIPHTHERIAE ANATOXINUM)
TETANUS TOXOID (TETANI ANATOXINUM)
POLIOMYELITIS VIRUS TYPE 1, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 1 INACTIVATUM)
POLIOMYELITIS VIRUS TYPE 2, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 2 INACTIVATUM)
POLIOMYELITIS VIRUS TYPE 3, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 3 INACTIVATUM)
PERTUSSIS TOXOID (PERTUSSIS ANATOXINUM)
PERTUSSIS FILAMENTOUS HAEMAGGLUTININ (PERTUSSIS HAEMAGGLUTININUM FILAMENTOSUM)
PERTACTIN (PERTACTINUM)
ATC group J07CA02
ATC group name DIFTERIE-PERTUSE-POLIOMYELITIDA-TETANUS

Marketing authorisation information

Registration Number 59/ 268/05-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 07. 2020
MA Holder GlaxoSmithKline Biologicals S.A., Rixensart
MA Holder country BELGIE
Actual MA holder GlaxoSmithKline Biologicals S.A., Rixensart
Actual MA holder country BELGIE

Back to list